Radiation Therapy Equipment Market size, share & Trends

Research Nester released a report titled “Metastatic Breast Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global metastatic breast cancer treatment market in terms of market segmentation by treatment type, end-user and region.Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.The metastatic breast cancer treatment market is projected to grow with a high CAGR during the forecast period, i.e., 2021-2029 on account of the increasing elderly population and the rising prevalence of breast cancer.

According to Globocan report 2020, the incidence rate of breast cancer was 5.20% which accounted for 2.26 million new cases globally with a mortality rate of 6.9%.The market is segmented by treatment type into chemotherapy, radiation therapy, biologic, targeted therapy, breast surgery, and hormone therapy.

Among these segments, the chemotherapy and radiation therapy is anticipated to hold the largest share by the end of 2021 in the metastatic breast cancer treatment market as a result of the lesser side-effects and high specificity rate.Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-2998On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the metastatic breast cancer treatment market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period.

This can be attributed to the presence of leading healthcare providers in the region, especially in the United States, who are extensively involved in the research and development for innovative metastatic breast cancer treatment.Increasing Ageing Population and Breast Cancer Prevalence to Drive Market GrowthAccording to the United Nations, it is estimated that by 2050, every one in six people will be 65 years or older, i.e., 16% of the total world population.

Along with this, the number of persons above 80 years or older is also projected to triple by the end of 2050.“The Final Report will cover the impact analysis of COVID-19 on this industry.”Download/Request Sample Copy of Strategic Report:  https://www.researchnester.com/sample-request-2998Increasing demand for metastatic breast cancer treatments has increased with the growing ageing population and the rise of new advanced technologies are some of the major factors that drive the growth of the global market.

However, the high risk associated with the radiation exposure along with lack of awareness are some of the factors that are estimated to restrain market growth in the near future.This report also provides the existing competitive scenario of some of the key players of the global metastatic breast cancer treatment market which includes company profiling of F. Hoffmann-La Roche Ltd, Merck & Company, Inc., AstraZeneca Plc., Novartis, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Johnson & Johnson, GlaxoSmithKline plc., and others.

According to the new market research report “Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) – Global Forecasts to 2025″, published by MarketsandMarkets™, global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market.

Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.Browse in-depth TOC on “Intraoperative Radiation Therapy Market”77 – Tables33 – Figures159 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Growing global prevalence of cancerThe IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue.

This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy).

The growing prevalence of cancer will increase the adoption of IORT procedures.By technology, the electron IORT segment is expected to grow at the highest rate during the forecast periodBased on technology, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy.

Global External Beam Radiation Therapy Market: OverviewExternal radiation (or external beam radiation) is the most common type of radiation therapy used for cancer treatment.

These machines focus the radiation on the exact location on the body so that normal tissues are affected as little as possible.External radiation is usually done during outpatient visits to a hospital or treatment center.

Most people undergo external radiation therapy over many weeks.

However, some people may need to go to the treatment center twice a day for a fewer number of weeks.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=64928Key Driver of Global External Beam Radiation Therapy MarketThe global external beam radiation therapy market is growing at a rapid pace owing to increase in incidence of cancerCancer is a serious health problem affecting a large population across the globe.

According to the WHO, 18 million new cancer cases were reported in 2018 across the world, and cancer causes around 8.2 million deaths annually.

Moreover, the number of cancer cases is likely to rise by 70% across the globe, with 60% of cases in Africa, Asia, and Latin America.Request COVID Analysis on External Beam Radiation Therapy Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=64928  Key Restraint of Global External Beam Radiation Therapy MarketAccording to WHO report, an estimated two-thirds of the planet does not have access to basic radiology services.

The Superficial Radiation Therapy System Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the superficial radiation therapy system market include Sensus Healthcare, Xstrahl Limited and Others.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Superficial Radiation Therapy System Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/superficial-radiation-therapy-system-market/download-sampleMarket DynamicsThe rising prevalence of skin cancer, across the globe, is primarily driving the market growth.

Superficial radiation therapy enables effective treatment with minimum postoperative complications is also boosting the market growth.

Along with this, ongoing R and rising efforts of major players for increasing the production capacity is expected to create potential demand over the forecast period.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.

This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.Request for the Report Summary: https://www.factmr.com/report/2572/mri-guided-radiation-therapy-system-marketThe study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market.

It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree.

In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019.

Opportunities abound for of MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2572The study also finds that radiotherapy centers are adopting technologically-advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective.

Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America.

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global market.

Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, growing at a CAGR of 7.0% from 2019 to 2024.

Intraoperative Radiation Therapy Market by Method (Electron IORT, Intraoperative Brachytherapy), Products & Services (Accelerators, Treatment Planning System, Applicators, Afterloaders, Accessories), Application (Breast, Brain).The intraoperative radiation therapy market comprises several stakeholders such as market product manufacturers, suppliers and distributors, healthcare service providers, and research institutes.

The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer.Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Based on method, the market is segmented into electron IORT and intraoperative brachytherapy.

The electron IORT segment is expected to grow at the highest rate in the market in 2019.

The growth of this segment can be attributed to the wide range of benefits associated with it, including lesser treatment time, better depth of penetration, and optimal dose homogeneity.On the basis of product & service, the market is segmented into IORT products and services.